ad image
Tuesday Sep 17, 2024

Day 10: Innovating Women’s Health & Operational Excellence in Sydney

Leading the Charge in Diagnostics for Women's Health

Day 10 of Road to the Max: Australia brought another full day of discoveries in Sydney, starting with a visit to BCAL Diagnostics. We met with Jayne Shaw, Executive Chair, who gave us a tour of their facility and lab. BCAL is dedicated to developing safer, more accessible, and cost-effective diagnostic tools and procedures for women’s health issues, and our time with them showcased the cutting-edge innovations they're bringing to the forefront of women’s healthcare. Next, we headed to Coogee Beach, where we met John Wrenn, Director of Operations at CAI. CAI specializes in providing professional services that enhance operational performance within the life sciences industry, and our conversation with John highlighted how their work is driving efficiency and performance improvements across the sector.

A Day at the Opera

No trip to Sydney is complete without a stop at the iconic Opera House, where we wrapped up the day with Shu Lam, Business Development Director at ProPharma. Shu picked up where her colleague Sharon Charles left off from Day 02, diving deeper into ProPharma’s efforts to support the pharmaceutical industry’s growth and innovation. From diagnostics to operational performance and business development, Day 10 was filled with key insights from leaders across the life sciences space. Stay tuned as we continue to explore what’s next on the Road to the Max: Australia!

BCAL DIagnostics
GenSight Biologics
Globyz
GI Therix
VIC.GOV.AU
Grand River
Granules
GreyRigge Associates
Grifols
Haig Barrett Partners
Hamilton
INCOG
NAS
propharma
Commissioning Agents International (CAI)
Navigating the Australian Clinical Trials Landscape

John Wrenn, Director of Operations, Australia & New Zealand at CAI, discusses how CAI supports life sciences companies in Australia and the APAC region. With expertise in complex project management, no-code technology, commissioning, compliance, training, and operational workflows, CAI helps clients navigate the regulatory landscape for clinical trials. John explains how CAI’s comprehensive approach ensures smooth, efficient, and compliant operations, enabling companies to bring their innovations to market with confidence.

Better Outcomes for Cancer Patients Begin with Screening

Jayne Shaw, Co-Founder and Executive Chair of BCAL Diagnostics, a biotechnology company focused on improving breast cancer screening and diagnostics, shares BCAL’s mission to provide early and accurate diagnoses, enabling timely intervention and better health outcomes for women. With a commitment to advancing breast cancer detection technology, BCAL Diagnostics is playing a vital role in empowering women and improving the effectiveness of cancer care.

An interview with John Wrenn, Director of Operations, Australia & New Zealand, at CAI.
Don't look directly into the camera!
Boys will be boys.
A cruise ship has made its way into the harbor. Bon voyage!
Shu Lam, Director of Business Development, APAC, at ProPharma.
Rocco doing his best "Blue Steel" face.
The local kids are clowning around.
Lucas's turn for an album cover shot.
Crashing waves on Coogee Beach.
Careful, Nigel, those rocks look slippery!
If you squint hard enough, you might be able to see New Zealand.
Our Road to the Max: Australia version of the signature road trip sand art.
A true artist can always find supplies, even in the most unexpected places.
Adama's ready for a swim.
Surf's up at Coogee Beach.
The BCAL Diagnostics lab team.
Jayne Shaw, Executive Chair at BCAL Diagnostics.
Kathy Koskiris, Director of Clinical Lab Services at BCAL Diagnostics.